FHS Updates
Twitter

Facebook

 

Search
e-Newsletter
 

View previous newsletters.

Our partner in Nigeria

Nigeria

Background

Nigeria is the 13th poorest country in the world with 70% living in poverty and 37.5% living in extreme poverty. This level of poverty affects everything from social cohesion and security to health. Malaria is a major cause of mortality and ill-health in Nigeria and has huge consequences for the productivity of the country. Many health systems in Nigeria have become increasingly pluralistic and poor people are faced with a confusing myriad of health providers and drug sellers. Old barriers between private and public, modern and traditional and formal and informal health providers are breaking down.

Systematic reviews of government health policies have shown the government’s determination to use research evidence to address the challenges of poverty. The government is targeting malaria as a way of reducing poverty. This is a key approach in addressing the first millennium development goal (MDG) ‘Eradicate extreme poverty and hunger’ and is highly relevant to a number of other MDG indicators such as the infant and maternal mortality rates.

FHS Phase 1

Given the Nigerian government's focus on malaria treatment and eradication, much of FHS Phase 1 work in Nigeria focused on that issue. In particular, they looked at the role of the informal sector, especially patent medicine vendors, in delivering malaria medications to patients in need.

FHS Phase 2

Nigeria is no longer a core country in which FHS is working in Phase 2. However, the team will continue to contribute to FHS's research as they examine the role of patent-medicine vendors in the anti-malarial market in Nigeria. This additional research is funded by the Center for Health Market Innovations.